LINCOLNSHIRE, Ill. – February 9, 2012 (Investorideas.com Newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study …

New York, New York – February 6, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for BioSante Pharmaceuticals, Inc. (NasdaqGM: BPAX), trading up at $1.0199, gaining 0.2799 (37.82%) 3:10PM EST. The Company has rebounded from its low of $0.38, now trading above $1.00 …

New York, New York – February 6, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Complete Genomics Inc. (Nasdaq:GNOM). The stock is trading up at $3.46, gaining 0.45 (14.95%) 11:03AM EST on over 1.7 Million shares. Investorideas.com Newswire About Complete Genomics (Nasdaq:GNOM) …

Biotage® introduced their 2012 catalog of analytical sample preparation products for chemistry professionals. Uppsala, Sweden, January 28, 2012 — Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced their 2012 catalog of analytical sample preparation products for chemistry professionals. The significantly enhanced 200 page edition includes a …

PISCATAWAY, N.J., Dec 22, 2011 – Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in global market. As the largest gene synthesis supplier worldwide, GenScript is dedicated to improve the quality and speed of gene synthesis by developing and applying innovative technologies. With the Rush …

POINT ROBERTS – November 28, 2011 – www.InvestorIdeas.com issues a biotech investor alert for Pharmasset, Inc. (Nasdaq:VRUS), Vertex Pharmaceuticals (VRTX) and Aethlon Medical, Inc. (OTCBB: AEMD), three stocks involved in the treatment of Hepatitis C Virus (HCV).   Over 170 million people worldwide are chronically infected with Hepatitis C. The sector made headlines earlier this …

Biotage® (STO: BIOT), a leading manufacturer of tools and technology for medicinal, organic, and analytical chemistry, introduced the new Isolera PrimeTM flash purification system. Uppsala, Sweden – November 10, 2011 — Biotage® (STO: BIOT), a leading manufacturer of tools and technology for medicinal, organic, and analytical chemistry, introduced the new Isolera PrimeTM flash purification system. …

Palo Alto, California – 9 November, 2011, PREMIER Biosoft today announced the release of a new version of SimGlycan®, its comprehensive, high throughput multi-stage MS data analysis tool. The program now includes support for adducts such as Li and K. Additionally, SimGlycan® 3.50 enables users to analyze MSn profiles using adduct combinations such as Na …

Biotage® introduced the new RapidTrace®+ SPE Workstation. RapidTrace+ is based on the widely accepted, industry standard RapidTrace platform. Uppsala, Sweden – October 18, 2011 — Biotage® (STO: BIOT), a leading manufacturer of tools and technology for analytical and medicinal chemistry, introduced the new RapidTrace®+ SPE Workstation. RapidTrace+ is based on the widely accepted, industry standard …

PISCATAWAY, N.J., Sep 15, 2011 – GenScript USA, Inc. filed in New Jersey court a law suit against GeneWiz Inc. for misappropriation of trade secret and unfair competition. GenScript will seek compensatory damages, permanent injunctions, and other remedies from GeneWiz.   GenScript USA, Inc. is a leading contract research organization (CRO) specialized in biological research …

Models of autism show that gene copy number controls brain structure and behavior. Cold Spring Harbor, N.Y – October 12, 2011 — Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered that one of the most common genetic alterations in autism—deletion of a 27-gene cluster on chromosome 16—causes autism-like features. By generating mouse models of …

NEEDHAM, MASS. – August 26, 2011 – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report, Authored by Hermann Mucke, PhD. By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of …

NEEDHAM, MASS. – August 26, 2011 – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances Report, Authored by Ken Rubenstein, PhD. This report focuses on current and innovative NGS technologies, services and markets to answer such questions as; •Which early NGS market entrants …

LONDON (August 9, 2011) – Invezz, one of UK’s up-and-coming boutique digital media companies, introduced today theirnewly launchedinvestments information portal, Carbon Markets (www.carbon-markets.co.uk). The website is designed to provide large corporations, small businesses and environmentally conscious individuals with valuable insights on the state, trends and forecasts of the dynamic carbon markets. “Carbon investments havebeen slowly …

For Immediate Release July, 18, 2011 – Scisense Systems Inc. hosts Dr. DeMarco from the University of Missouri. Dr. DeMarco will give an overview and summary of the PV loop data from transgenic Ren2 and Zucker obese rat models. Furthermore, he will review the results describing the cardiac dysfunction and address some of the technicalities …

A YOUNG mother, who always wanted to work in science but lacked the confidence to pursue her dream career, is now a rising star in a Midlothian company which is a world leader in stem cell technology, thanks to the Modern Apprenticeship scheme and her own hard work. Twenty-nine-year-old Emma Clarke had spent her working …

Biotage introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide Symposium in San Diego, California USA. Uppsala, Sweden, July 12, 2011 — Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide …

Uppsala, Sweden, July 08, 2010 — Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, announced a new microwave synthesizer with state of the art user interface and industry leading operating range. The Biotage Initiator+ sets a new standard by delivering new opportunities for chemistry professionals needing to …

A large variety of processes, few of which are exactly alike, typical unit operations share many commonalities. One of these is the requirement for accurate process analytics in order to help maximize product quality and yield and to minimize costs. Measurement of pH, ORP, conductivity, DO or turbidity may seem like small parts of a …

As per our new research report “Israel Life Sciences Market Analysis”, Israeli Life Science companies in general have witnessed impressive returns via IPOs, mergers, and acquisitions. It has been found in our research that, the value of M&A’s and IPO’s in Israeli Life Sciences companies totaled US$ 822 Million in 2009. The main drivers for …

Biotage (STO: BIOT), announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy. Uppsala, Sweden, June 01, 2011 — Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinapl chemistry, announced a collaborative research agreement with The Laboratory of Peptide & …

For more information: Lisa Scimemi Insight Pharma Reports 781-972-5446  FOR IMMEDIATE RELEASE Insight Pharma Reports Announces Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report  NEEDHAM, MASS.  – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report, Authored by Lucy Sannes, MBA, PhD. Biomarkers feature in thousands of published articles each …

Uppsala, Sweden, May 26, 2011 — Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced 2 new instruments that utilize positive pressure for solid-phase extraction (SPE) of analytes in a wide variety of applications. The Biotage PRESSURE+ 96 processes 96-well SPE plates and the Biotage PRESSURE+ 48 processes …

Uppsala, Sweden, April 20, 2011 — Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of sample preparation products with the launch of EVOLUTE WAX. EVOLUTE WAX is a mixed-mode weak anion exchanger, developed for the extraction of strongly acidic analytes from …

SAN DIEGO – April 15, 2011 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB: AEMD) the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that InvestorIdeas.com has released an interview with Aethlon CEO Jim Joyce regarding broad spectrum treatment strategies to address HIV, Hepatitis C and other infectious disease conditions. The …

(Thorold) – Norton Scientific is proud to announce the company concluded a deal with Prisma Biotech of Taiwan and has ended its first quarter of the year on a very positive note. Bryan Webb, President of Norton, explains market acceptance of their PAM protein monitoring tool has increased dramatically since its introduction at PITTCON 2011 …

Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, has launched baculoFECTIN. Oxford, UK, April 04, 2011 – Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, has launched baculoFECTIN. This new non-toxic transfection reagent has been optimized for use in insect cells and proven to produce greater levels …

(Thorold) - In accordance with their sales growth strategy for North America, Brian Webb, President of Norton Scientific, is pleased to announce the company has concluded two sales representation deals with experienced professionals covering key customer clusters in New England and the Mid West.  These latest agreements extend sales coverage to include the main biotechnology clusters …

Uppsala, Sweden, March 24, 2011 — Biotage® (STO: BIOT), a leading supplier of tools and technology for medicinal, analytical and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis. The Workstation utilizes a unique microwave peptide vial available in two sizes; 2-5 mL for 75-150 µmol scale or 10-20 mL for …

Piscataway, New Jersey, Mar 23rd, 2010 – GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. GANP (Germinal Center Associated Nuclear Protein) is a protein discovered by Dr. Nobuo Sakaguchi at Kumamoto …